Adenoviral conjunctivitis is a common condition that is aggressively contagious, and therefore, requires early diagnosis. Often the best course of action is to let the infection run its course; however, some possible treatments are currently being investigated. One of these is a combination of dexamethasone and povidone-iodine, which is hoped will remove the infection quicker and reduce inflammation. The other experimental treatment is brincidofovir, which has shown efficacy in systemic adenoviral infection, though not specifically in the eye. In an expert interview filmed at AAO 2018, editorial board member Dr Bennie Jeng discusses the complications and potential treatment options for adenoviral conjunctivitis. He explains that while treatment with corticosteroids is not ideal, and something he tries to avoid, it can sometimes be necessary for highly symptomatic patients or those with subepithelial infiltrates which could result in scarring. Infiltrates can be very responsive to steroids; however, they may reoccur many times, leaving the patient reliant on steroids for an extended time. Dr Jeng explains how to manage these patients and the best methods for tapering patients off steroids.
1. What are the common clinical presentations of adenoviral conjunctivitis? (0:11)
2. What are the consequences of delayed diagnosis of adenoviral conjunctivitis? (0:32)
3. What are the most effective ways of managing the condition? (1:12)
4. What is your opinion on the use of corticosteroids for the treatment of subepithelial infiltrates? (3:17)
Speaker disclosures: Bennie Jeng has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Corneal Disorders
Sunil Shah, EURETINA 2020 – Khmer Sight Foundation and Photon Ultraviolet C Device (Part 2)
It was a pleasure to catch up with our Editorial Board member, Prof. Sunil Shah (Birmingham and Midland Eye Centre, Birmingham, UK), who explained the impact of the Photon Ultraviolet C (UVC) device that he has developed. Questions Could you give us an overview of the health burden of corneal infections in developing countries? (00:08) […]
Sunil Shah, EURETINA 2020 – Khmer Sight Foundation and Photon Ultraviolet C Device (Part 1)
It was a pleasure to catch up with our Editorial Board member, Prof. Sunil Shah (Birmingham and Midland Eye Centre, Birmingham, UK), who updated us on the aims of the Khmer Sight Foundation. Questions Could you tell us a little about The Khmer Sight Foundation and its objectives? (00:09) How did you become involved with […]
Jorge Alió, ESCRS 2020 – Advanced Therapy for Corneal Disease
It was a pleasure to catch up with our Editorial Board member, Prof. Jorge Alió (Miguel Hernandez University, Alicante, Spain), who talked us through his presentation at ESCRS on advanced therapy for corneal disease. Questions What are the major unmet needs in the treatment of corneal disease? (00:22) Could you give us an overview […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!